Cyclenium Pharma

Cyclenium Pharma is a private and emerging pharmaceutical R&D company. The company aims to leverage its next-generation CMRT macrocycle drug discovery technology to identify new small-molecule therapies for challenging disease targets in areas of unmet medical need, enabling physicians to find useful innovative drugs for less common diseases. Cyclenium creates value by advancing its internal programs in oncology, infectious diseases, inflammation, and pain.